Investors will be keen to know the sales number of AstraZeneca’s new products Airsupra (asthma), Voydeya (paroxysmal nocturnal hemoglobinuria) and Wainua (ATTRv-PN) as well as AstraZeneca and ...

Investors will be keen to know the sales number of AstraZeneca’s new products Airsupra (asthma), Voydeya (paroxysmal nocturnal hemoglobinuria) and Wainua (ATTRv-PN) as well as AstraZeneca and partner ...

Credit: Getty Images The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products. Below is a review of novel drug and biological products ...

The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions. Below is a review of novel drug and biological products ...